Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Heart Failure
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
93%
Patients with Heart Failure
46%
Spironolactone
29%
95% Confidence Interval
27%
Heart Failure Hospitalization
26%
Hazard Ratio
26%
Cardiac Function
26%
Chronic Heart Failure
24%
Cardiovascular Mortality
21%
TOPCAT Trial
20%
TOPCAT
20%
Aldosterone Antagonists
19%
Adverse Outcomes
18%
Ventricular Assist Device
18%
Left Ventricular Ejection Fraction
17%
Clinical Outcomes
15%
Ejection Fraction
15%
Dilated Cardiomyopathy
15%
Preserved Ejection Fraction
12%
Advanced Heart Failure Therapies
10%
All-cause Mortality
10%
Acute Decompensated Heart Failure
10%
Heart Failure Patients
9%
Heart Rate
9%
Placebo
9%
Left Ventricular Assist Device
9%
Patient Characteristics
8%
Precision Medicine
8%
Cardiac Structure
8%
Prognostic Importance
8%
Vericiguat
8%
Aborted Cardiac Arrest
8%
COVID-19
7%
PARAGON-HF
7%
Influenza Vaccination
7%
Affordable Care Act Medicaid Expansion
7%
Readmission
7%
Patient Outcomes
7%
Clinical Trials
7%
Diastolic Function
7%
Heart Transplant
7%
B-type Natriuretic Peptide
7%
Influenza Vaccine
7%
First Degree Relatives
7%
High Risk
7%
N-terminal pro-B-type Natriuretic Peptide (NT-proBNP)
6%
Cardiovascular Outcomes
6%
Human Heart Failure
6%
Atrial Fibrillation
6%
Medicine and Dentistry
Congestive Heart Failure
94%
Heart Failure with Preserved Ejection Fraction
47%
Cardiovascular System
28%
Heart Function
23%
Aldosterone Antagonist
19%
Hazard Ratio
19%
Ejection Fraction
18%
Spironolactone
17%
Dilated Cardiomyopathy
15%
Adverse Outcome
15%
Ventricular Assist Device
11%
Heart Left Ventricle Ejection Fraction
11%
Diastolic Function
9%
Systolic Function
8%
Personalized Medicine
8%
Cardiac Structure
8%
Frailty
8%
Brain Natriuretic Peptide
8%
Biological Marker
8%
Clinical Trial
8%
Quality of Life
8%
COVID-19
7%
Systolic Blood Pressure
7%
Heart Graft
7%
Diabetes Mellitus
7%
Diseases
6%
Left Ventricular Assist Device
6%
Heart Arrest
6%
Left Ventricular Hypertrophy
6%
Prevalence
6%
Placebo
5%
Echocardiography
5%
Heart Failure with Reduced Ejection Fraction
5%
Morbidity
5%
Cardiovascular Disease
5%
Genetics
5%
Sex Differences
5%
Medicaid
5%
Cardiac Resynchronization Therapy
5%
Left Ventricular Systolic Dysfunction
5%
Outpatient
5%
Myocardial Infarction
5%